Dr. Lieberman/Boston Children's - New Study for Triple Negative

Danjulieo

There is a new study in the journal Cancer Cell discussing data that triple negative breast cancers may respond to treatment with drugs similar to a proteasome inhibitor that revolutionized the care of patients with the blood cancer multiple myeloma, and there are already FDA approved proteasome inhibitor drugs, so testing this new approach in at risk cancer patients should be possible.                                                       

Has anyone else learned any more about these FDA approved drugs and the effects of this treatment?  Have there been earlier posts about this?  Thank you.  

Meggy

Thank you for telling us about this.  Anything new is so hopefull.